{"url_path":"/sec/mrai/8-k/2026-07-20/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-20","source_url":"https://www.sec.gov/Archives/edgar/data/1844392/0001213900-26-079599-index.html","accession_number":"0001213900-26-079599","cik":"0001844392","ticker":"MRAI","issuer_name":"Marpai, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1844392/0001213900-26-079599-index.html","primary_entity_key":"0001844392","primary_entity_name":"Marpai, Inc."},"word_count":95,"has_tables":true,"body_markdown":"**Item 9.01 Financial Statements and Exhibits.**\n\n** **\n\n(d) Exhibits\n\n \n\n**Exhibit\nNumber**\n \n**Description**\n\n10.1\n \n[Amendment No. 2 to Purchase Agreement by and between Marpai, Inc. and AXA S.A., a French société anonyme.](ea029856901ex10-1.htm)\n\n99.1\n \n[Press release.](ea029856901ex99-1.htm)\n\n104\n \nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n 1\n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of the Securities\nExchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \nMARPAI, INC.\n\n \n \n \n\nDate: July 20, 2026\nBy:\n/s/ Damien Lamendola\n\n \n \nName: \nDamien Lamendola\n\n \n \nTitle:\nChief Executive Officer\n\n \n\n 2"}